Abstract
The susceptibility of 11,840 clinical bacterial isolates to fortimicin A was determined by agar dilution or broth microdilution methods and compared with their susceptibility to amikacin and gentamicin. In general, the in vitro activity of fortimicin A was essentially the same as that of amikacin. Significant exceptions were the increased effectiveness of fortimicin A against Serratia marcescens and the greater activity of amikacin against Pseudomonas and other nonfermentative gram-negative bacilli. On a weight-for-weight basis, gentamicin showed greater activity than the other two antimicrobial drugs against most species; S. Marcescens was the major exception. However, at concentrations equivalent to achievable nontoxic serum levels, the proportion of isolates inhibited by the three drugs was quite comparable. There were several strains with unusually high resistance to one or more of the tested antibiotics. These usually occurred in one of the six participating institutions and could be traced to specific enzyme-producing or permeability mutants endemic to that particular institution.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Egan R. S., Stanaszek R. S., Cirovic M., Mueller S. L., Tadanier J., Martin J. R., Collum P., Goldstein A. W., De Vault R. L., Sinclair A. C. Fortimicins A and B, new aminoglycoside antibiotics. III. Structural identification. J Antibiot (Tokyo) 1977 Jul;30(7):552–563. doi: 10.7164/antibiotics.30.552. [DOI] [PubMed] [Google Scholar]
- Ericsson H. M., Sherris J. C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;217(Suppl):1+–1+. [PubMed] [Google Scholar]
- Fuchs P. C., Gavan T. L., Gerlach E. H., Jones R. N., Barry A. L., Thornsberry C. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates. Am J Med Sci. 1977 Nov-Dec;274(3):255–263. [PubMed] [Google Scholar]
- Girolami R. L., Stamm J. M. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides. J Antibiot (Tokyo) 1977 Jul;30(7):564–570. doi: 10.7164/antibiotics.30.564. [DOI] [PubMed] [Google Scholar]
- Jones R. N., Fuchs P. C., Gavan T. L., Gerlach E. H., Barry A. L., Thornsberry C. Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates. Antimicrob Agents Chemother. 1977 Jul;12(1):47–50. doi: 10.1128/aac.12.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R. N., Fuchs P. C., Gavan T. L., Gerlach E. H., Barry A., Thornsberry C. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates. J Antibiot (Tokyo) 1977 Jul;30(7):576–582. doi: 10.7164/antibiotics.30.576. [DOI] [PubMed] [Google Scholar]
- Nara T., Yamamoto M., Kawamoto I., Takayama K., Okachi R., Takasawa S., Sato T., Sato S. Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins. J Antibiot (Tokyo) 1977 Jul;30(7):533–540. doi: 10.7164/antibiotics.30.533. [DOI] [PubMed] [Google Scholar]
- Sato S., Iida T., Okachi R., Shirahata K., Nara T. Enzymatic acetylation of fortimicin A and seldomycin factor 5 by aminoglycoside 3-acetyltransferase I: [AAC(3)-I] of E. coli KY8348. J Antibiot (Tokyo) 1977 Nov;30(11):1025–1027. doi: 10.7164/antibiotics.30.1025. [DOI] [PubMed] [Google Scholar]